| 1 day | -1.13% |
| 3 years | 4.81 |  | 31.5 |
| 5 years | 4.81 | | 64.5 |
| 10 years | 4.81 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Evan Loh
CEO | Chief Executive Officer | 67 | 21/05/2025 |
| Chief Tech/Sci/R&D Officer | - | 01/01/2020 | |
Jonathan Neely
IRC | Investor Relations Contact | - | 01/08/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Evan Loh
BRD | Director/Board Member | 67 | 21/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/05/25 | Issuer sale | Chief Financial Officer | 82,491 | 0.8204% | ||
| 21/05/25 | Issuer sale | Director | 12,624 | 0.1255% | ||
| 21/05/25 | Issuer sale | Director | 12,624 | 0.1255% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.13% | -.--% | - | - | 9.72Cr | |
| +0.47% | +0.03% | +55.37% | +129.19% | 1,14000Cr | |
| +0.32% | +2.98% | +40.36% | +83.45% | 64TCr | |
| -0.30% | -1.17% | +25.28% | +105.63% | 51TCr | |
| -0.11% | +1.49% | +47.98% | +66.44% | 38TCr | |
| +0.31% | -5.30% | +59.59% | +36.58% | 35TCr | |
| +0.97% | +2.18% | +25.30% | +54.32% | 29TCr | |
| -0.33% | +1.46% | +2.04% | +26.45% | 27TCr | |
| +0.17% | +1.23% | +52.61% | +69.87% | 24TCr | |
| -0.97% | +0.45% | +30.51% | +105.19% | 20TCr | |
| Average | -0.06% | +2.92% | +37.67% | +75.24% | 44.6TCr | |
| Weighted average by Cap. | +0.18% | +2.98% | +41.72% | +87.92% |
Employees
128
Sector
Pharmaceuticals
